{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:53:47Z","timestamp":1787828027550,"version":"build-2784847793"},"reference-count":45,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2019,10,24]]},"DOI":"10.3233\/jhd-180318","type":"journal-article","created":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T03:32:19Z","timestamp":1570246339000},"page":"449-457","source":"Crossref","is-referenced-by-count":8,"title":["Increased Serotonin Transporter Expression in Huntington\u2019s Disease Patients Is Not Consistently Replicated in Murine Models"],"prefix":"10.1177","volume":"8","author":[{"given":"Yanqing","family":"He","sequence":"first","affiliation":[{"name":"Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA"},{"name":"Xiangya Hospital, Central South University, Changsha, Hunan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalikun","family":"Suofu","sequence":"additional","affiliation":[{"name":"Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svitlana","family":"Yablonska","sequence":"additional","affiliation":[{"name":"Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Wang","sequence":"additional","affiliation":[{"name":"Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Larkin","sequence":"additional","affiliation":[{"name":"Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinho","family":"Kim","sequence":"additional","affiliation":[{"name":"Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane L.","family":"Carlisle","sequence":"additional","affiliation":[{"name":"Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Friedlander","sequence":"additional","affiliation":[{"name":"Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JHD-180318_ref1","doi-asserted-by":"crossref","unstructured":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell. 1993;72(6):971\u201383.","DOI":"10.1016\/0092-8674(93)90585-E"},{"issue":"6769","key":"10.3233\/JHD-180318_ref2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/35000576","article-title":"Motor disorder in Huntington\u2019s disease begins as a dysfunction in error feedback control","volume":"403","author":"Smith","year":"2000","journal-title":"Nature"},{"issue":"6555","key":"10.3233\/JHD-180318_ref3","doi-asserted-by":"crossref","first-page":"378403a0","DOI":"10.1038\/378403a0","article-title":"Polyglutamine expansion as a pathological epitope in Huntington\u2019s disease and four dominant cerebellar ataxias","volume":"378","author":"Trottier","year":"1995","journal-title":"Nature"},{"issue":"9557","key":"10.3233\/JHD-180318_ref4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.3233\/JHD-180318_ref5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1176\/jnp.17.4.496","article-title":"Depression and stages of Huntington\u2019s disease","volume":"17","author":"Paulsen","year":"2005","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"6","key":"10.3233\/JHD-180318_ref6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"10.3233\/JHD-180318_ref7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00441-017-2670-4","article-title":"Serotonin in psychiatry: in vitro disease modeling using patient-derived neurons","volume":"371","author":"Vadodaria","year":"2018","journal-title":"Cell Tissue Res"},{"issue":"1","key":"10.3233\/JHD-180318_ref8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1471-4159.2007.04542.x","article-title":"Plasma serotonin levels and the platelet serotonin transporter","volume":"102","author":"Brenner","year":"2007","journal-title":"J Neurochem"},{"issue":"7599","key":"10.3233\/JHD-180318_ref9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nature17629","article-title":"X-ray structures and mechanism of the human serotonin transporter","volume":"532","author":"Coleman","year":"2016","journal-title":"Nature"},{"issue":"8","key":"10.3233\/JHD-180318_ref10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.parkreldis.2011.05.012","article-title":"Serotonin and dopamine striatal innervation in Parkinson\u2019s disease and Huntington\u2019s chorea","volume":"17","author":"Bedard","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"10.3233\/JHD-180318_ref11","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/nsmb.1602","article-title":"Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures","volume":"16","author":"Zhou","year":"2009","journal-title":"Nat Struct Mol Biol"},{"issue":"3","key":"10.3233\/JHD-180318_ref12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0165-0327(98)00221-3","article-title":"Mechanism of action of serotonin selective reuptake inhibitors: Serotonin receptors and pathways mediate therapeutic effects and side effects","volume":"51","author":"Stahl","year":"1998","journal-title":"J Affect Disord"},{"issue":"Supplement 3","key":"10.3233\/JHD-180318_ref13","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0924-977X(99)00030-9","article-title":"Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders","volume":"9","author":"Nutt","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"10.3233\/JHD-180318_ref14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s11940-013-0219-8","article-title":"Treatment of huntington disease","volume":"15","author":"Videnovic","year":"2013","journal-title":"Curr Treat Options Neurol"},{"key":"10.3233\/JHD-180318_ref15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fncel.2017.00142","article-title":"The effect of serotonin-targeting antidepressants on neurogenesis and neuronal maturation of the hippocampus mediated via 5-HT1A and 5-HT4 receptors","volume":"11","author":"Segi-Nishida","year":"2017","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"10.3233\/JHD-180318_ref16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ana.20075","article-title":"Paroxetine retards disease onset and progression in Huntingtin mutant mice","volume":"55","author":"Duan","year":"2004","journal-title":"Ann Neurol"},{"issue":"8","key":"10.3233\/JHD-180318_ref17","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/j.1460-9568.2005.04365.x","article-title":"Cognitive disorders and neurogenesis deficits in Huntington\u2019s disease mice are rescued by fluoxetine","volume":"22","author":"Grote","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JHD-180318_ref18","first-page":"2179","article-title":"Transgenic animal models for study of the pathogenesis of Huntington\u2019s disease and therapy","volume":"9","author":"Chang","year":"2015","journal-title":"Drug Des Devel Ther"},{"issue":"2-3","key":"10.3233\/JHD-180318_ref19","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.brainresbull.2011.07.021","article-title":"Gene expression and behaviour in mouse models of HD","volume":"88","author":"Bowles","year":"2012","journal-title":"Brain Res Bull"},{"issue":"6","key":"10.3233\/JHD-180318_ref20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbadis.2009.04.001","article-title":"Mouse models of Huntington\u2019s disease and methodological considerations for therapeutic trials","volume":"1792","author":"Ferrante","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.3233\/JHD-180318_ref21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-6147(00)01884-8","article-title":"Mouse models of Huntington\u2019s disease","volume":"23","author":"Menalled","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.3233\/JHD-180318_ref22","unstructured":"Menalled L , Lutz C , Ramboz S , Brunner D , Lager B , Noble S , Park L , Howland D . A Field Guide to Working with Mouse Models of Huntington\u2019s Disease. The Jackson Laboratory, 2014."},{"key":"10.3233\/JHD-180318_ref23","first-page":"509","article-title":"Twenty-first century brain banking. Processing brains for research: the Columbia University methods","author":"Vonsattel","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.3233\/JHD-180318_ref24","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nn.3721","article-title":"Inhibition of mitochondrial protein import by mutant huntingtin","volume":"17","author":"Yano","year":"2014","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.3233\/JHD-180318_ref25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","article-title":"Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats","volume":"465","author":"Menalled","year":"2003","journal-title":"J Comp Neurol"},{"key":"10.3233\/JHD-180318_ref26","doi-asserted-by":"crossref","first-page":"37052","DOI":"10.1074\/jbc.M305514200","article-title":"Serotonin and cocaine-sensitive inactivation of human serotonin transporters by methanethiosulfonates targeted to transmembrane domain I","volume":"278","author":"Henry","year":"2003","journal-title":"J Biol Chem"},{"key":"10.3233\/JHD-180318_ref27","first-page":"20","article-title":"Physical interactions and functional relationships of neuroligin 2 and midbrain serotonin transporters","volume":"7","author":"Ye","year":"2015","journal-title":"Front Synaptic Neurosci"},{"issue":"6","key":"10.3233\/JHD-180318_ref28","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"issue":"33","key":"10.3233\/JHD-180318_ref29","doi-asserted-by":"crossref","first-page":"23004","DOI":"10.1074\/jbc.M113.495754","article-title":"The serotonin transporter undergoes constitutive internalization and is primarily sorted to late endosomes and lysosomal degradation","volume":"289","author":"Rahbek-Clemmensen","year":"2014","journal-title":"J Biol Chem"},{"issue":"4","key":"10.3233\/JHD-180318_ref30","first-page":"673","article-title":"Characterization of the binding sites for 123I-ADAM and the relationship to the serotonin transporter in rat and mouse brains using quantitative autoradiography","volume":"45","author":"Lin","year":"2004","journal-title":"J Nucl Med"},{"issue":"11","key":"10.3233\/JHD-180318_ref31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tins.2010.08.002","article-title":"Early synaptic pathophysiology in neurodegeneration: insights from Huntington\u2019s disease","volume":"33","author":"Milnerwood","year":"2010","journal-title":"Trends Neurosci"},{"key":"10.3233\/JHD-180318_ref32","doi-asserted-by":"crossref","first-page":"41570","DOI":"10.1038\/srep41570","article-title":"Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6. Htt(Q111\/+) model of Huntington\u2019s disease","volume":"7","author":"Bragg","year":"2017","journal-title":"Sci Rep"},{"issue":"6733","key":"10.3233\/JHD-180318_ref33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/20446","article-title":"Inhibition of caspase-1 slows disease progression in a mouse model of Huntington\u2019s disease","volume":"399","author":"Ona","year":"1999","journal-title":"Nature"},{"issue":"5","key":"10.3233\/JHD-180318_ref34","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1046\/j.1471-4159.2003.02105.x","article-title":"Sequential activation of individual caspases, and of alterations in Bcl-2 proapoptotic signals in a mouse model of Huntington\u2019s disease","volume":"87","author":"Zhang","year":"2003","journal-title":"J Neurochem"},{"issue":"4","key":"10.3233\/JHD-180318_ref35","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington\u2019s disease transgenic mice","volume":"490","author":"Stack","year":"2005","journal-title":"J Comp Neurol"},{"issue":"1","key":"10.3233\/JHD-180318_ref36","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuroscience.2008.08.041","article-title":"Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in Knock-in Huntington\u2019s disease mice","volume":"157","author":"Hickey","year":"2008","journal-title":"Neuroscience"},{"issue":"12","key":"10.3233\/JHD-180318_ref37","doi-asserted-by":"crossref","first-page":"e0143563","DOI":"10.1371\/journal.pone.0143563","article-title":"RNA sequence analysis of human huntington disease brain reveals an extensive increase in inflammatory and developmental gene expression","volume":"10","author":"Labadorf","year":"2015","journal-title":"PloS One"},{"issue":"7","key":"10.3233\/JHD-180318_ref38","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.drudis.2014.02.014","article-title":"The many faces of autophagy dysfunction in Huntington\u2019s disease: from mechanistic pathways to therapeutic opportunities","volume":"19","author":"Cortes","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.3233\/JHD-180318_ref39","doi-asserted-by":"crossref","first-page":"14089","DOI":"10.1038\/ncomms14089","article-title":"Direct PIP2 binding mediates stable oligomer formation of the serotonin transporter","volume":"8","author":"Anderluh","year":"2017","journal-title":"Nat Commun"},{"issue":"4","key":"10.3233\/JHD-180318_ref40","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1021\/bi0508688","article-title":"The C-terminus is critical for the functional expression of the human serotonin transporter","volume":"45","author":"Larsen","year":"2006","journal-title":"Biochemistry"},{"issue":"14","key":"10.3233\/JHD-180318_ref41","doi-asserted-by":"crossref","first-page":"9388","DOI":"10.1074\/jbc.M706367200","article-title":"Serotonin transamidates Rab4 and facilitates its binding to the C terminus of serotonin transporter","volume":"283","author":"Ahmed","year":"2008","journal-title":"J Biol Chem"},{"issue":"39","key":"10.3233\/JHD-180318_ref42","doi-asserted-by":"crossref","first-page":"28901","DOI":"10.1074\/jbc.M602848200","article-title":"Subcellular redistribution of the serotonin transporter by secretory carrier membrane protein 2","volume":"281","author":"Muller","year":"2006","journal-title":"J Biol Chem"},{"key":"10.3233\/JHD-180318_ref43","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrn3570","article-title":"Choosing an animal model for the study of Huntington\u2019s disease","volume":"14","author":"Pouladi","year":"2013","journal-title":"Nat Rev Neurosci"},{"issue":"38","key":"10.3233\/JHD-180318_ref44","doi-asserted-by":"crossref","first-page":"E7997","DOI":"10.1073\/pnas.1705768114","article-title":"Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release","volume":"114","author":"Suofu","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.3233\/JHD-180318_ref45","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","article-title":"Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington\u2019s disease","volume":"23","author":"Cepeda","year":"2003","journal-title":"J Neurosci"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-180318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:50:52Z","timestamp":1777452652000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-180318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,24]]},"references-count":45,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jhd-180318","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,24]]}}}